ArticleBreathe (Sheffield, England)2021

Pro: Access to advanced therapies for severe asthma should be restricted to patients with satisfactory adherence to maintenance treatment.

Anna C Murphy et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.